NLRP3 and cancer: Considering that inflammasome is implicated in TNBC development and progression, numerous studies have focused on discovering the potential anti-cancer strategies of inflammasome components, such as the identification of possible NLRP3, IL-1β or CASP1 inhibitors (MCC950 or AcYVAD-cmk) or the identification of ncRNA molecules that intervene at the transcriptional level.